110145-65-8Relevant academic research and scientific papers
Synthesis and biological evaluation of new N-substituted 4-(arylmethoxy)piperidines as dopamine transporter inhibitors
Lapa, Gennady B.,Lapa, Alla A.
, p. 203 - 205 (2019/04/25)
The library of new N-substituted 4-(arylmethoxy)piperidines as dopamine transporter inhibitors was designed and synthesized. H-Bond donors in piperidine ring were found to be important for reduced locomotor activity in mice. 4-[Bis(4-fluorophenyl)methoxy]piperidine has IC50 17.0 ± 1.0 nm for dopamine transporter and locomotor activity, which is lower than that for cocaine.
Vascular effects of diphenylmethoxypiperidine-derived dopamine uptake inhibitors
Pulgar, Victor M.,Keith Harp, Jill
, p. 2429 - 2432 (2014/05/20)
Vascular effects of 4-aryl methoxypiperidinol compounds previously shown to share with cocaine the ability to inhibit the dopamine transporter are described. All the compounds tested inhibit KCl-induced and noradrenaline- dependent contractions in mesente
The synthesis and biological evaluation of dopamine transporter inhibiting activity of substituted diphenylmethoxypiperidines
Lapa, Gennady B.,Byrd, Gary D.,Lapa, Alla A.,Budygin, Evgeny A.,Childers, Steven R.,Jones, Sara R.,Harp, Jill J.
, p. 4915 - 4918 (2007/10/03)
The synthesis of potent 4-aryl methoxypiperidinol inhibitors of the dopamine transporter is described. Symmetrical para substituents of the benzene rings are important for high potency in binding to the dopamine transporter. 4-[Bis(4-fluorophenyl) methoxy]-1-methylpiperidine has an IC50 of 22.1 ± 5.73 nM and increases locomotor activity in mice.
